Page last updated: 2024-09-04

vatalanib and gadolinium

vatalanib has been researched along with gadolinium in 1 studies

Compound Research Comparison

Studies
(vatalanib)
Trials
(vatalanib)
Recent Studies (post-2010)
(vatalanib)
Studies
(gadolinium)
Trials
(gadolinium)
Recent Studies (post-2010) (gadolinium)
276429813,8385196,282

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drevs, J; Dugan, M; Laurent, D; Morgan, B; Steward, WP; Thomas, AL; Unger, C; Vanhoefer, U; Wiedenmann, B1

Reviews

1 review(s) available for vatalanib and gadolinium

ArticleYear
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
    Seminars in oncology, 2003, Volume: 30, Issue:3 Suppl 6

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Clinical Trials as Topic; Colorectal Neoplasms; Contrast Media; Drug Screening Assays, Antitumor; Gadolinium; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Phthalazines; Pyridines; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2

2003